Oracle Laboratories Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 15 Year, 11 Days
- Last Filing with ROC 31 Mar 2018
- Open Charges ₹ 1.00 M
- Revenue Growth 212.83%
- Profit Growth 268.43%
- Ebitda 63.43%
- Net Worth 48.38%
- Total Assets 106.13%
About Oracle Laboratories
Oracle Laboratories Private Limited (OLPL) is a Private Limited Indian Non-Government Company incorporated in India on 05 February 2010 and has a history of 15 years. Its registered office is in Delhi, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2018. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹1.00 M.
Rupali Bansal and Vikas Bansal serve as directors at the Company.
Company Details
-
Location
Delhi, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U24100DL2010PTC198755
-
Company No.
198755
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
05 Feb 2010
-
Date of AGM
30 Sep 2018
-
Date of Balance Sheet
31 Mar 2018
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Oracle Laboratories?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rupali Bansal
|
Additional Director | 29-May-2019 | Current |
|
Vikas Bansal
|
Director | 05-Feb-2010 | Current |
Financial Performance of Oracle Laboratories.
Oracle Laboratories Private Limited, for the financial year ended 2018, experienced significant growth in revenue, with a 212.83% increase. The company also saw a substantial improvement in profitability, with a 268.43% increase in profit. The company's net worth Soared by an impressive increase of 48.38%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Oracle Laboratories?
In 2018, Oracle Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹1.00 M
₹0
Charges Breakdown by Lending Institutions
- Punjab & Sind Bank : 0.10 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 Mar 2012 | Punjab & Sind Bank | ₹1.00 M | Open |
How Many Employees Work at Oracle Laboratories?
Unlock and access historical data on people associated with Oracle Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Oracle Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Oracle Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
